May 17, 2020

The NightWave Sleep Assistant as a tool to end insomnia

NightWave Sleep Assistant
sleeping pills
2 min
NightWave Sleep Assistant
Written by Syndey Johnston With economic turmoil all over the globe, ordinary people are suffering from insomnia. After all, worrying about money is ex...

Written by Syndey Johnston

With economic turmoil all over the globe, ordinary people are suffering from insomnia. After all, worrying about money is extremely stressful and we humans are most likely to fall prey to the demons of stress and anxiety at night rather than during the active, sunshine-filled hours of the day. Rather than relying on dangerous sleeping pills, some people are turning to technology and one of the most popular insomnia-fighters is the NightWave Sleep Assistant.

It works by shining a soft, pulsating blue light onto your ceiling and you simply follow the changes in the light while synchronizing your breathing with its rhythm. There are two cycles: seven minutes and 25 minutes and the light slowly dims and turns itself off. The directions suggest experimenting with the seven minute cycle first and only using the longer one if necessary.

There are multiple advantages to this simple technology

1. This is a natural sleep aid, rather than a chemical one and is clearly better for your body than any drug can ever be.

2. Drugs often become habit forming and don't work with the natural cycles of the body, whereas the NightWave Sleep Assistant does, in fact, promote natural rest. What is more basic to the human body than our own personal breathing patterns?

3. It is recommended by doctors, including the famous Dr. Oz.

4. It is totally safe for children which is reassuring to any parent who would hesitate to use prescription drugs on their young children. In fact, many children will be intrigued by what they perceive as a game and will be eager to follow the blue light.

5. It is soundless, making it non-invasive and soothing, unlike some sound machines that are   popular as sleep aids.

6. There are no wires and no electricity is needed. This makes the NightWave portable so the owner can use it to sleep anywhere, under any conditions.

7. Users claim that it doesn't disturb a bed partner in a way other technology might. Since the blue light is on the ceiling, anyone who sleeps soundly can simply close their eyes and ignore it.

8. It is definitely cheaper than using prescription sleeping pills which will cost considerable money over time.

It's always wise to try a natural method first before dragging out the "big guns" of drugs and sleep clinics. It should be considered as the first step to solve sleeping problems. Hopefully, it will be your last step.

Share article

Jun 18, 2021

Skin Analytics wins NHSX award for AI skin cancer tool 

2 min
Skin Analytics uses AI to detect skin cancer and will be deployed across the NHS to ease patient backlogs

An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system. 

NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion. 

Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making. 

In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog. 

Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening. 

DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.

Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.

Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges. 

"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”

Share article